---
id: 1444995181829361668
author: stephensenn
published_date: 2021-10-04 11:57:52 +00:00
conversation_id: 1444682020030910468
in_reply_to: 1444994460283244550
retweet: None
quoted_tweet: None
type: tweet
tags:
keywords:
- fda
- would
- see
- warning
- applies
- analysis
- proposing
- trial
- using
- called
- under
- group
- parallel

---

@yudapearl @ESteyerberg @LinkedIn @Lester_Domes @MariaGlymour @NP_Jewell 2/2) You are using what would be a called a cluster randomised trial but you are proposing the analysis that applies for a parallel group trial. The FDA would not let you do that.
See the warning under "disadvantages" here https://t.co/8BrNQ56A4B

[View tweet on Twitter.com](https://twitter.com/stephensenn/status/1444995181829361668)

### Metadata

Author: [[@stephensenn]]
Conversation: [[conversation-1444682020030910468]]
In reply to: [[1444994460283244550]]
Retweet of: [[None]]
Quoted tweet: [[None]]
Published Date: [[calendar/2021-10-04]]
keywords:
- [[index/fda|fda]]
- [[index/would|would]]
- [[index/see|see]]
- [[index/warning|warning]]
- [[index/applies|applies]]
- [[index/analysis|analysis]]
- [[index/proposing|proposing]]
- [[index/trial|trial]]
- [[index/using|using]]
- [[index/called|called]]
- [[index/under|under]]
- [[index/group|group]]
- [[index/parallel|parallel]]
